CEFODIZIME SODIUM PDF

Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author: Nikohn Samusho
Country: Azerbaijan
Language: English (Spanish)
Genre: Video
Published (Last): 4 May 2015
Pages: 85
PDF File Size: 8.15 Mb
ePub File Size: 20.26 Mb
ISBN: 875-3-13175-614-7
Downloads: 89452
Price: Free* [*Free Regsitration Required]
Uploader: Groshicage

Nitroaspirin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Nitroaspirin. Further information on drug naming conventions: Heparin Cerodizime therapeutic efficacy of Heparin can be decreased when used in combination with Cefotaxime. Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Cefotaxime. Chromium nicotinate Cefotaxime may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.

Varenicline Cefotaxime may decrease the excretion rate of Varenicline which could result in a higher serum level. Ethosuximide The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Cefotaxime. Micronomicin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Micronomicin.

Alprazolam Cefotaxime may decrease the excretion rate of Alprazolam which could result in a higher serum level. Foscarnet The risk or severity of nephrotoxicity can be increased when Cefodizume is combined with Foscarnet. Desipramine Cefotaxime may decrease the excretion rate of Desipramine which could result in a higher serum level. Cefodisime The cefoizime or severity of nephrotoxicity can be increased when Cefotaxime is combined with Suprofen.

Salicylamide The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Salicylamide.

Cefodizime

Dopamine Cefotaxime may decrease the excretion rate of Dopamine which could result in a higher serum level. Sulbactam Cefotaxime may decrease the excretion rate of Sulbactam which could result in a higher serum level.

Oxacillin Cefotaxime may decrease the excretion rate cefodozime Oxacillin which could result in a higher serum level. Ipecac Cefotaxime may decrease the excretion rate of Ipecac which could result in a higher serum level. Chlorpromazine Cefotaxime may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.

  EL TROMPO DE JOSE DIEZ CANSECO PDF

Oseltamivir Cefotaxime may decrease the excretion rate of Oseltamivir which could result in a higher serum level. Vancomycin Cefotaxime may decrease the excretion rate of Vancomycin which could result in a higher serum level. Didanosine Cefotaxime may decrease the excretion rate of Didanosine which could result in a higher serum level.

Digoxin Cefotaxime may decrease the excretion rate of Digoxin which could result in a higher serum level. Hygromycin B The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Hygromycin B. Barbital The therapeutic efficacy of Barbital can be decreased when used in combination with Cefotaxime. Testosterone Cefotaxime may decrease the excretion rate of Testosterone which could result in a higher serum level.

Dalfampridine Cefotaxime may decrease the excretion rate of Dalfampridine which could result in a higher serum level. Flavoxate Cefotaxime may decrease the excretion rate of Flavoxate which could result in a higher serum level. Valbenazine Cefotaxime may decrease the excretion rate of Valbenazine which could result in a higher serum level.

Lixisenatide Cefotaxime may decrease the excretion rate of Lixisenatide which could result in a higher serum level. Apramycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Apramycin. Leucovorin The excretion of Leucovorin can be decreased when combined cefodiziem Cefotaxime.

Trimethoprim Cefotaxime may decrease the excretion rate of Trimethoprim which could result in a higher ceofdizime level.

Cefodizime sodium (CAS 86329-79-5)

Apremilast Cefotaxime may decrease the excretion rate of Apremilast which could result in a cdfodizime serum level. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal socium records. Bisoxatin Cefotaxime may decrease the excretion rate of Bisoxatin which could result in a higher serum level.

Tobramycin The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Tobramycin. Levocarnitine Cefotaxime may decrease the excretion rate of L-Carnitine which could result in a higher serum level. Aminohippuric acid The excretion of Aminohippuric acid can be decreased when combined with Cefotaxime. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy.

  BADIOU POCKET PANTHEON PDF

Clodronic acid The risk or severity socium nephrotoxicity and hypocalcemia can be increased when Cefotaxime is combined with Clodronic Acid.

Fentiazac The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Fentiazac.

Cefotaxime – DrugBank

Ifenprodil The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Cefotaxime. Pidotimod Cefotaxime may decrease the excretion rate of Pidotimod which could result in a higher serum level.

Pemetrexed Cefotaxime may decrease the excretion rate of Cefodiaime which could result in a higher serum level. Bivalirudin The therapeutic efficacy of Bivalirudin ssodium be decreased when used in combination with Cefotaxime. Memantine Cefotaxime may decrease the excretion rate of Memantine which could result in a higher serum level. Penbutolol Cefotaxime may decrease the excretion rate of Penbutolol which could result in a higher serum level.

Anagrelide The therapeutic efficacy of Anagrelide can be decreased when used in combination with Cefotaxime.

Cefodizime – Wikipedia

Potassium Citrate The therapeutic efficacy of Potassium Citrate can be decreased when used in combination with Cefotaxime. Peginesatide Cefotaxime may decrease the excretion rate of Peginesatide which could result in a higher serum level. Typhoid Vaccine The therapeutic efficacy of Typhoid Vaccine can be decreased when used in combination with Cefotaxime.

Ceforanide The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Ceforanide. Pentaerythritol tetranitrate Cefotaxime may decrease the excretion rate of Pentaerythritol Tetranitrate which could result cefodixime a higher serum level. Medazepam The therapeutic efficacy of Medazepam can be decreased when used in combination with Cefotaxime.

Sulthiame The therapeutic efficacy of Sulthiame can be decreased when used in combination with Cefotaxime. Difenpiramide The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Difenpiramide.

Ardeparin The therapeutic efficacy of Ardeparin can be decreased when used in combination with Cefotaxime.